Company profile
Hummingbird Bioscience company profile
Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Revenue range
- $1M-$10M
- Founded
- 2014-01-01, Year
Headquarters
- Headquarters
- Woodlands, North Region, Singapore
- Postal code
- 117604
- Country code
- SG
- Continent
- Asia